CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US Patients
Author
Barbara H. Johnson
BJ Chastek
+17Â more
CH Polman
Coulthard-Morris L Clinical
Crystal Watson
D Pelletier
DA Ollendorf
DE Ho
DS Goodin
DS Goodin
E Havrdova
H Butzkueven
I Elovaara
JA Nicholas
L Prosperini
Machaon M. Bonafede
MM Bonafede
OH Kantarci
R Lanzillo
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
Get PDF
Crossref